Skip to main content

Table 1 Agreement on first-choice treatment recommendation for management of dentin hypersensitivity

From: Concordance between practitioner questionnaire responses and observed clinical treatment recommendations for treatment of dentin hypersensitivity: findings from the National Dental Practice-Based Research Network

Treatment Recommended

Product Listed as First Choice on Survey

Agreement Between Survey and Exam

Kappa

n (%)

% (95% CI)

(95% CI)

Desensitizing OTC Potassium

Nitrate Toothpaste

84 (49.1%)

63.7% (56.1, 70.9)

0.27 (0.13, 0.42)

Fluoride Products

62 (36.3%)

63.2% (55.5, 70.4)

0.22 (0.07, 0.37)

Glutaraldehyde/HEMA Products

6 (3.5%)

95.9% (91.8, 98.3)

0.20 (−0.16, 0.57)

Advice

6 (3.5%)

93.0% (88.1, 96.3)

− 0.04 (−0.06, − 0.02)

Other

6 (3.5%)

88.9% (83.2, 93.2)

0.13 (−0.08, .034)

Restorative Treatments

2 (1.2%)

97.1% (93.3, 99.0)

0.27 (−0.17, 0.71)

No Treatment

2 (1.2%)

96.5% (92.5, 98.7)

−0.02 (−0.03, − 0.003)

Bonding Agents

1 (0.6%)

95.9% (91.8, 98.3)

−0.01 (−0.03, 0.01)

Lasers

1 (0.6%)

99.4% (96.8, 100.0)

1.0 (1.0, 1.0)

Oxalates

1 (0.6%)

97.1% (93.3, 99.0)

−0.01 (−0.02, 0.01)

Sealants

0 (0%)

99.4% (96.8, 100.0)

---

  1. N = 171
  2. 95% confidence intervals in parentheses
  3. --- kappa not calculable due to the contingency table having a row containing only zero counts